Clinical Trials Logo

Myopathy clinical trials

View clinical trials related to Myopathy.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04941079 Not yet recruiting - Covid19 Clinical Trials

Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients :a Prospective Observational Study

Start date: June 30, 2021
Phase:
Study type: Observational [Patient Registry]

This study is a prospective observational study. We aim to investigate the safety and efficacy of inactivated SARS-CoV-2 vaccine between immune-related myopathy (myasthenia gravis and inflammatory myopathy) patients and health controls. The main study factors include adverse events following immunization (AEFI), serum specific antibody (Acetylcholine receptor (AChR) antibody, Anti-MuSK (muscle-specific kinase) antibody, myositis antibody) and virus neutralizing antibody titers.

NCT ID: NCT03633565 Not yet recruiting - Myopathy Clinical Trials

Comparative Study of Strategies for Management of Duchenne Myopathy (DM)

Start date: September 2018
Phase: Phase 4
Study type: Interventional

1. Comparing different lines of treatment of Duchenne Myopathy (DM) and assessment of new lines of treatment (mesenchymal stem cell, phosphodiesterase inhibitors) in reducing the impact of disability in the patients with Duchenne Myopathy and slowing the progression of cardiomyopathy 2. Upsetting and implementation of the best treatment plan for those children with Duchenne myopathy which is suitable for the available resources in Assiut University Children Hospital